MERRIMACK PHARMACEUTICALS INC reports

Company location: Cambridge, MA
Fiscal year end: 31 December

MERRIMACK PHARMACEUTICALS INC has filed 807 SEC EDGAR filings since 29 Dec 2003

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 101-125 of 802 matching filings.

Per page

25

Current page

5

4

FORM 4 SUBMISSION

Filing date: 23 Feb 2022
Reporting date: 18 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Feb 2022
Reporting date: 16 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Feb 2022
Reporting date: 14 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-86778

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-86778

SC 13G/A

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Feb 2022
Reporting date: 28 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Jan 2022
Reporting date: 27 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Jan 2022
Reporting date: 26 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 27 Jan 2022
Reporting date: 26 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2022
Reporting date: 24 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Jan 2022
Reporting date: 18 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Jan 2022
Reporting date: 13 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jan 2022
Reporting date: 11 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Jan 2022
Reporting date: 07 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jan 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35409

8-K

Filing date: 04 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-35409

10-Q

Filing date: 04 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 20 Sep 2021
Reporting date: 14 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35409

8-K

Filing date: 05 Aug 2021
Reporting date: 05 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-35409

10-Q

Filing date: 05 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35409

8-K

Filing date: 14 Jun 2021
Reporting date: 10 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Jun 2021
Reporting date: 10 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Jun 2021
Reporting date: 10 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .